Mct formulations for increasing ketone exposure and methods of making and using such formulations
AssigneesSociete des Produits Nestle S.A., Socpra Sciences Sante Et Humaines S.E.C.
InventorsBernard Cuenoud, Stephen Cosgrave Cunnane
Life of this patent
Estimating the term…
Abstract
A composition effective for treating or preventing a condition for which extended exposure to ketones is beneficial contains medium chain triglycerides (MCTs) and also contains proteins in a weight ratio of at least 0.1 g protein/1.0 g of the compound. Other aspects are directed to a method of extending blood exposure to ketones derived from oral absorption of a food product by an individual; a method of improving or maintaining at least one of neurologic health, cognitive function, or exercise performance; and a method of making the composition.
Claims20
A method of extending blood exposure to ketones derived from oral absorption of a food product by an individual, the method comprising administering to the individual a composition comprising medium chain triglycerides (MCTs) and further comprising proteins in a weight ratio of at least 0.1 g protein/1.0 g of the MCTs.
(canceled)
6-11. (canceled)
16-17. (canceled)
(canceled)
A method of treating or preventing a condition for which extended exposure to ketones is beneficial, the method comprising administering to an individual a composition comprising medium chain triglycerides (MCTs) and further comprising proteins in a weight ratio of at least 0.1 g protein/1.0 g of the MCTs.
A method of improving or maintaining at least one of neurologic health, cognitive function, or exercise performance, the method comprising administering to an individual a composition comprising medium chain triglycerides (MCTs) and further comprising proteins in a weight ratio of at least 0.1 g protein/1.0 g of the compound.
26-31. (canceled)
Dependencies are inferred from the claim text.